Skip to main content
. 2010 Jun 11;3(3):191–199. doi: 10.1159/000314611

Table 3.

Subjects’ hormonal and lipid-lipoprotein profiles before and after our walking program (means ± SD)

Premenopausal women (n = 16)
Postmenopausal women (n = 14)
before after before after
FSH, IU/l 12.82 ± 18.72a 16.67 ± 15.13 81.76 ± 22.72 81.91 ± 16.81
Estradiol, pmol/l 424.47 ± 317.25b 551.40 ± 396.08 77.93 ± 46.77 68.00 ± 25.12
Triacylgycerol, mmol/l 1.14 ± 0.59 1.25 ± 0.69 1.46 ± 0.74 1.54 ± 0.90
Cholesterol, mmol/l 5.28 ± 1.07 4.72 ± 1.07c 5.54 ± 1.02 5.48 ± 1.08c
LDL cholesterol, mmol/l 3.33 ± 0.92 2.98 ± 0.65c 3.35 ± 0.78 3.33 ± 0.79
HDL cholesterol, mmol/l 1.41 ± 0.29b 1.35 ± 0.28c 1.52 ± 0.49 1.43 ± 0.46c
CHOL/HDL cholesterol 3.86 ± 1.05 3.74 ± 0.77 3.92 ± 1.17 4.12 ± 1.23
Apolipoprotein B, g/l 0.98 ± 0.20 0.99 ± 0.17 1.05 ± 0.25 1.06 ± 0.20

FSH = Follicle stimulating hormone; LDL = low-density lipoprotein; HDL = high-density lipoprotein; CHOL = cholesterol.

a

p < 0.0001;

b

p < 0.01: significant difference between pre- and postmenopausal women at baseline, after adjustment for age.

c

p < 0.05: significant difference before and after walking, after adjustment for age.